Literature DB >> 9950028

The death receptors.

M E Peter1, C Scaffidi, J P Medema, F Kischkel, P H Krammer.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 9950028     DOI： 10.1007/978-3-540-69184-6_3

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN： 0080-1844


× No keyword cloud information.
  15 in total

1.  Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function.

Authors:  Tara L Garvey; John Bertin; Richard M Siegel; G H Wang; Michael J Lenardo; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Molecular ordering of the initial signaling events of CD95.

Authors:  Alicia Algeciras-Schimnich; Le Shen; Bryan C Barnhart; Andrea E Murmann; Janis K Burkhardt; Marcus E Peter
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.

Authors:  J P Medema; J de Jong; L T Peltenburg; E M Verdegaal; A Gorter; S A Bres; K L Franken; M Hahne; J P Albar; C J Melief; R Offringa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

4.  A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.

Authors:  S T Eichhorst; M Müller; M Li-Weber; H Schulze-Bergkamen; P Angel; P H Krammer
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

5.  Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling.

Authors:  Christine Feig; Vladimir Tchikov; Stefan Schütze; Marcus E Peter
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

Review 6.  TRAIL/Apo-2L: mechanisms and clinical applications in cancer.

Authors:  R K Srivastava
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

7.  Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication.

Authors:  Keith J Micoli; Olga Mamaeva; Sabine C Piller; Jennifer L Barker; George Pan; Eric Hunter; Jay M McDonald
Journal:  Virology       Date:  2005-10-17       Impact factor: 3.616

8.  Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.

Authors:  Pachiyappan Kamarajan; Nian-Kang Sun; Chuck C-K Chao
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

9.  Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.

Authors:  Timothy F Fernandez; Alexandra B Samal; Gregory J Bedwell; Yabing Chen; Jamil S Saad
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

10.  Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

Authors:  Martin R Sprick; Eva Rieser; Heiko Stahl; Anne Grosse-Wilde; Markus A Weigand; Henning Walczak
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.